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A B S R A C T
Purpose: The study aim was to examine association between leisure time physical activity (LTPA) and psy-
chiatric comorbidities among people with depression.
Methods: Total 447 patients aged 35 years and older suffering from depressive symptoms (DS) and who were
confirmed depression positive participated this study. The study was conducted between 2008 and 2011 in
municipalities within Central Finland Hospital District. DS were determined with Beck Depression Inventory
(BDI-21) with cutoff score ≥10 and psychiatric diagnoses were confirmed by Mini-International
Neuropsychiatric Interview (M.I.N.I.). LTPA, other diseases as well as use of antidepressant were captured by
self-reported questionnaire. Participants also took part in physical examination. The associations between LTPA
and psychiatric comorbidities were analyzed using generalized linear models.
Results: LTPA level was not related to number of psychiatric comorbidities (after adjustment for age, gender,
BMI, BDI and use of antidepressant p=0.24) among depressed patients. The higher levels of LTPA were linearly
associated with lower cardiovascular diseases (p=0.036) and obesity (p=0.006) as well as fewer DS
(p < 0.001) among depressed patients.
Limitations: Possibility of LTPA level overestimation and study results generalizability to younger persons.
Conclusions: According to this study, LTPA level is not associated with psychiatric comorbidities among de-
pressed patients in Finnish adult population. However, our results showed that the higher the LTPA level was,
the less the participants suffered from depressive symptoms. In addition, higher levels of physical activity were
associated with fewer heart diseases and obesity outlining the importance of overall health-care and health
promotion although other forms of treatment are also needed.
1. Introduction
Depression is one of the most disability causing illnesses in the
world (Whiteford et al., 2013) and its economical and individual
burden are huge. Depression is often associated with one or more other
psychiatric disorder and together they can impact one's life dramati-
cally. Over 70% of depression diagnosed patients have at least one
other psychiatric comorbidity (Kessler et al., 2003). Patient suffering
from mental illnesses has over two-fold higher risk of early death
compare to people in general and their life expectancy is ten years
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shorter (Walker et al., 2015). Depression together with psychiatric co-
morbidities are found to increase the sensation of pain and decrease
one's performance and quality of life (Bair et al., 2008). Depression is
also associated with increased risk of many somatic diseases such as
obesity, diabetes and cardiovascular diseases (Penninx et al., 2013).
According to recent knowledge leisure time physical activity (LTPA)
is useful for treating and preventing depression. Physical activity re-
duces depressive symptoms (DS) in people with mental illness
(Rosenbaum et al., 2014) and physically active individuals have lower
risk for depression in the future compared to in-active ones (Mammen
and Faulkner, 2013; Schuch et al., 2018). According to review of
Mammen and Faulkner (2013) any physical activity (PA) level, in-
cluding low levels (e.g., walking <150 min/weeks), may prevent for
future depression. Recent large United States (US) nationwide study
(Chekroud et al., 2018) has revealed that physical exercised and phy-
sically active individuals had nearly 43% fewer poor mental health days
than those who not in the past month. The relationship between PA and
depression is also bidirectional, increased PA can reduce depressive
symptoms as well as depression itself can reduce PA (Sieverdes et al.,
2012).
As depression is often associated with multiple psychiatric co-
morbidities (Kessler et al., 2003), it is still largely unknown whether or
how amount of LTPA is related to psychiatric comorbidities among
depressive patients. Depression by itself and particularly with addi-
tional psychiatric comorbidities is not only individual misery but huge
societal burden (Mrazek et al., 2014;Sobocki et al., 2006) and therefore
it is sensible to figure out means and factors to resolve or at least reduce
these negative effects of illness. Most of the previous studies in-
vestigating the relationship between depression and LTPA have not
took psychiatric comorbidity into account or psychiatric comorbidities
are excluded. Thus, the main aim of this study as a part of Finnish
Depression and Metabolic Syndrome Study (FDMSA) is to explore the
relationship between LTPA and psychiatric comorbidities among de-
pressive diagnosed patients.
2. Materials and methods
2.1. Participants
The study data were drawn from the Finnish Depression and
Metabolic Syndrome in Adults (FDMSA) study which was conducted
between 2008 and 2011 in municipalities within Central Finland
Hospital District with catchment area of 274 000 inhabitants. The po-
pulation of this study were enrolled from 35 years of age or older pa-
tients (n=730) with depressive symptoms determined with Beck
Depression Inventory (BDI-21) with cutoff score ≥10. Participants
were self-referred or referred by general practitioners to depression
nurse case managers and who's psychiatric diagnoses were confirmed
by diagnosis structured interview (M.I.N.I.) conducted by depression
nurse case managers. Total 447 patients received a diagnosis of de-
pression. The Ethics Committee of the Central Finland Hospital District
approved the study protocol prior to the commencement of the study.
All participants signed an informed written consent.
2.2. Data sources
All participants filled out a standard self-administered questionnaire
containing questions about previously diagnosed somatic disorders, use
of antidepressant, smoking habits, number of alcohol doses per week
and leisure time physical activity (LTPA). Data on participants’ socio-
economical background such as years of education, marital and em-
ployment status were also collected via questionnaire. Participants also
took part on physical examination during the study visit. The physical
examination included measurements of participants’ weight and height
during the study visit. Weight and height were measured in light
clothing and was accurate to the nearest 0.5 cm and 0.1 kg,
respectively. The body mass index (BMI) was defined as person's weigth
(body mass) divided by the square of the heigth. Obesity were defined
when BMI ≥ 30 (World Health Organization, 2018).
LTPA was assessed by asking:“ How often do you do physical ac-
tivity at least for half an hour so that you are out of breath and
sweating?” Answers were classified into three levels: low (twice per
month or less), moderate (once or twice per week), or high (three times
per week or more). In previous studies self-assessed LTPA has shown a
high correlation with physical fitness as measured by maximal oxygen
uptake (Aires et al., 2003).
The severity of depressive symptoms (DS) was captured using the
21-item Beck Depression Inventory (BDI-21) (Beck et al., 1961), which
was completed by the participants. The cut-off point was set to ≥ 10
(Koponen et al., 2015). The psychiatric diagnosis and number of other
psychiatric comorbidities were confirmed and obtained with a diag-
nostic Mini-International Neuropsychiatric Interview (M.I.N.I.)
(Sheehan et al., 1998) delivered by trained study nurse.
2.3. Statistical methods
The results were presented as means with standard deviations (SD)
or as counts with percentages. Statistical significance for the unadjusted
analyses of linearity across the LTPA categories were evaluated using
the Cochran-Armitage test, Cuzick test and analysis of variance with an
appropriate contrast. Adjusted analyses of linearity (orthogonal poly-
nomial) were evaluated using generalized linear models (e.g. analysis of
co-variance, regression models and logistic models) with appropriate
distribution and link function. Models included age, gender, years of
education, marital status, comorbid diseases and household income as
covariates. In the case of violation of the assumptions (e.g. non-nor-
mality), a bootstrap-type method was used (10 000 replications) to
estimate standard errors. The normality of variables was evaluated by
the Shapiro–Wilk W test. All analyses were performed using STATA
14.1.
3. Results
Table 1 shows the socio-demographic and clinical characteristics of
the participants according to LTPA levels. BMI (p=0.005) and de-
pressive symptoms (p < 0.001), and further proportion of subjects with
cardiovascular diseases (p=0.036) and obesity (p=0.006) decreased
linearly across increasing LTPA categories. Although antidepressant
was used by 68% (n=305) of participants, there were no linear asso-
ciation between the LTPA level and use of antidepressant (p=0.53),
nor with other clinical or socio-demographic characteristics either
(Table 1).
The prevalence of psychiatric comorbidities among all depressed
participants (n=447) were as follow: generalized anxiety disorder
(GAD) 56%, suicidal 49%, panic disorder 25%, social phobia 16%, al-
cohol abuse or dependence 15%, hypomania 12%, agoraphobia 6%,
posttraumatic stress reaction 6%, obsessive-compulsive disorder (OCD)
6%, bulimia or anorexia 2% and psychosis 2% (Table 2). Only one-fifth
(23%) of the participants had no psychiatric comorbidity. More than
one third (38%) of the participants had one comorbidity, 22% had two
and 17% had at least three psychiatric comorbidities. Participants with
one or more psychiatric comorbidities were younger (50 years vs. 53
years) and smoked more often (34% vs. 23%, p=0.023) than those
without psychiatric comorbidities. Instead there were no difference in
gender, BMI or educational years among participants with or without
psychiatric comorbidities.
The statistical analysis revealed that LTPA level was not related to
number of psychiatric comorbidities (p=0.24). In addition, there was
no significant linear relationship between the prevalence of psychiatric
comorbidities and physical active level after adjusting the results for
age, gender, BMI, BDI score and use of antidepressant (Table 2).
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4. Discussion
4.1. Main findings and study implications
Our findings suggested that LTPA is not associated with psychiatric
comorbidities in patients with depressive symptoms. However, as in
line with some earlier findings (Barengo et al., 2017; Korniloff et al.,
2010) our study showed that LTPA had positive association with such
health-related factors as DS obesity and CVD in depressive patients.
This is important, since it has been shown in recent review that people
with severe mental illness with low LTPA has increased risk of cardi-
ovascular disease and premature mortality (Vancampfort et al., 2017).
Because PA, in general, has positive effect on mental health, it
would be expected that these positive effects of PA are reflected on
psychiatric comorbidities as well. Although, for example
Bartley et al. (2013) have concluded in their meta-analysis that current
evidence does not support the use of aerobic exercise as an effective
treatment for anxiety disorders as compared to other treatment. In our
study, the majority of study participants suffered from GAD (56%) and
as PA seems to be useful in depression it may have lesser impact on
depression with anxiety disorder (Bartley et al., 2013). This could be
one reason why LTPA does not seem to have positive association with
psychiatric comorbidities in this study.
There are also neurobiological changes associated with depression
e.g. in hypothalamic-pituitary-adrenal (HPA)- axis homeostasis, neu-
rotransmitters, neurogenesis and inflammatory markers where PA
could work as a “scaffolding” factor that support amelioration processes
(Archer et al., 2014). Again, neurotic disorders might “purely” associate
more with “mind” than “body”. This could also explain, at least partly,
why positive health effects of PA associated more clearly with pure
depression but not depression with additional psychiatric disorders and
that PA can reduce depressive symptoms but not necessarily psychiatric
comorbidities.
Recent study of Chekroud et al. (2018) has also revealed that while
physical exercise is in general useful for mental health, more exercise is
not always better and that the optimal amount lies between 30 and
60min per day three to five times a week. As depression itself can re-
duce PA (Sieverdes et al., 2012), neurotic disorders might force one to
move more and therefore neutralize depressions effects on PA. This
phenomenon might be reflected in our study also because we were not
able to catch those who exercise “more”. Nor we did not use objective
PA measurement instead of subjective assessment nor we didn't know
Table 1
Depressed patients’ socio-demographic and clinical characteristics at baseline.
Variables Total Leisure time physical activity P-value*
N=447 Low
N=111
Moderate
N=185
High
N=151
Female, n (%) 312 (70) 82 (74) 129 (70) 101 (67) 0.23
Age, years (SD) 51 (10) 49 (9) 52 (10) 51 (10) 0.055
BMI, mean (SD) 28.0 (5.9) 28.9
(6.3)
28.4 (6.0) 26.9
(5.2)
0.005
Obesity, (BMI
≥30), n (%)
143 (32) 43 (39) 65 (35) 35 (23) 0.006
Education years
(SD)
11.0 (3.0) 11.0
(2.9)
11.2 (3.1) 10.8
(3.1)
0.50
Married or
cohabited, n
(%)
266 (60) 68 (61) 103 (56) 95 (66) 0.23
Employment status,
n (%)
0.28
Employed 202 (45) 55 (50) 84 (45) 63 (42)
Unemployed 113 (25) 32 (29) 41 (22) 40 (26)
Student 11 (2) 4 (4) 4 (2) 3 (2)
Retired 121 (27) 20 (18) 56 (30) 45 (30)
Smoking, n (%) 142 (32) 47 (42) 49 (26) 46 (30) 0.067
Alcohol, doses per
week, n (%)
0.99
None 95 (21) 25 (23) 35 (19) 35 (23)
1–5 251 (56) 62 (56) 109 (59) 80 (53)
6–9 41 (9) 6 (5) 19 (10) 16 (11)
≥10 60 (13) 18 (16) 22 (12) 20 (13)
BDI score, mean
(SD)
23.4 (8.2) 25.4
(8.6)
23.4 (8.2) 22.0
(7.7)
<0.001
Antidepressant, n
(%)
305 (68) 75 (68) 123 (66) 107 (71) 0.53
Disease, n (%)
Neurological 11 (2) 4 (4) 2 (1) 5 (3) 0.99
Cancer 3 (1) 0 (0) 2 (1) 1 (1) 0.58
CVD 73 (16) 10 (9) 34 (18) 29 (19) 0.036
Rheumatic 15 (3) 4 (4) 9 (5) 2 (1) 0.25
Lung 42 (9) 10 (9) 12 (6) 20 (13) 0.18
DM 64 (14) 18 (16) 23 (12) 23 (15) 0.90
BDI beck depression inventory, CVD cardiovascular disease, DM diabetes mel-
litus.
⁎ p for linearity across the LTPA categories.
Table 2
Psychiatric comorbidities among depressed patients according to leisure-time physical activity level at baseline.
Variables Total Leisure time physical activity P for linearity*
N=447 Low N=111 Moderate N=185 High N=151
GAD, n (%) 250 (56) 68 (61) 101 (54) 81 (54) 0.62
Suicidal, n (%) 218 (49) 60 (54) 86 (46) 72 (48) 0.97
Panic disorder, n (%) 111 (25) 26 (23) 46 (25) 39 (26) 0.24
Alcohol abuse or dependence, n (%) 65 (15) 17 (15) 25 (14) 23 (15) 0.93
Social phobia, n (%) 71 (16) 20 (18) 30 (16) 21 (14) 0.83
Hypomania, n (%) 55 (12) 16 (14) 17 (9) 22 (15) 0.57
Posttraumatic stress reaction, n (%) 27 (6) 9 (8) 13 (7) 5 (3) 0.41
Agoraphobia, n (%) 28 (6) 9 (8) 9 (5) 10 (7) 0.84
OCD, n (%) 26 (6) 8 (7) 7 (4) 11 (7) 0.45
Bulimia or anorexia, n (%) 11 (2) 7 (6) 1 (1) 3 (2) 0.68
Psychosis, n (%) 7 (2) 3 (3) 2 (1) 2 (1) 0.69
Number of psychiatric comorbidities, mean (SD) 1.5 (1.3) 1.6 (1.4) 1.4 (1.2) 1.4 (1.2) 0.24
Number, n (%)
0 102 (23) 23 (21) 44 (24) 35 (23)
1 169 (38) 37 (33) 77 (42) 55 (36)
2 99 (22) 28 (25) 38 (21) 33 (22)
>=3 77 (17) 23 (21) 26 (14) 28 (19)
GAD generalized anxiety disorder, OCD obsessive-compulsive disorder.
⁎ p for linearity across the LTPA categories, adjusted for gender, age, BMI, BDI and use of antidepressant.
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what kind of PA lifestyle each participant had before the study due to
cross sectional study design. This may have affected to these results
also.
With these study findings without more extensive investigation we
cannot say what is the relevance of LTPA in depression in terms of
psychiatric comorbidities. While these findings can increase and widen
our knowledge about factors related to depression, it also raises ques-
tions about methods and tools which are suitable in prevention and
treatment of illness. As PA has many health benefits in depression it´s
suitability as treatment method to reduce psychiatric comorbidities
associated with depression are arguable. Therefore, further research
and more knowledge from the underlying factors behind these study
findings are needed.
4.2. Strengths and limitations
The main strength of this study is the use of diagnostic interview
(M.I.N.I.) to confirm depression and psychiatric comorbidities. Another
strength of this study is national representative study population with
catchment area of 274 000 inhabitants. Main limitation lies on the self-
reported LTPA which may prone to overestimation by participants.
Although, a self-reported questionnaire has proven to be a valid and
reliable method to measure PA in cross-sectional studies (Aires et al.,
2003) and in this study design we were not trying to estimate exact
amount and intensity of PA instead of crude LTPA level categorization.
Moreover, generalization of study results to younger persons cannot be
done due to study population of 35 and older in this study. Also, gen-
eralizability to other countries might be questionable as in Finnish so-
ciety social equity is in very high level and for example physical edu-
cation and health promotion as well as health services are well
organized compared many other countries.
5. Conclusion(s)
LTPA level was not associated with psychiatric comorbidities among
depressive diagnosed patients. This may suggest a different pathophy-
siology in depression and anxiety disorders as the level of LTPA was
inversely associated with depressive symptoms. However, higher levels
of physical activity associated with fewer heart diseases and obesity
highlights the importance of LTPA promotion in the treatment of co-
morbid depression although other forms of treatment for comorbid
anxiety disorders are also needed.
Funding
This research did not receive any specific grant from funding
agencies in the public, commercial, or not-for-profit sectors.
CRediT authorship contribution statement
Ilkka Raatikainen: Writing - original draft. Pekka Mäntyselkä:
Conceptualization, Methodology, Project administration, Writing - re-
view & editing. Mauno Vanhala: Conceptualization, Methodology,
Writing - review & editing. Ari Heinonen: Supervision, Writing - re-
view & editing. Hannu Koponen: Conceptualization, Methodology,
Writing - review & editing. Hannu Kautiainen: Data curation, Formal
analysis, Software, Writing - review & editing. Katariina Korniloff:
Conceptualization, Methodology, Writing - review & editing.
Declaration of Competing Interest
The authors declare that they have no conflict of interest.
Acknowledgments
The authors would like to thank the depression nurse case managers
who took part in the practical implementation of the FDMSA: Mari
Alanko, Harri Back, Timo Hannula, Anu Holopainen, Ritva Häkkinen,
Katja Johansson, Eija Kinnunen, Kaija Luoma, Hannele Niemi, Hillevi
Peura, Inga Pöntiö, Kirsi Rouvinen, Tiina Silvennoinen and Marianne
Vihtamäki; the FDMSA study nurses Anne Kirmanen, Seija Torkkeli,
Reetta Oksanen and Olli Niemi, and Pia Jauhiainen, scientific secretary
of the study.
Supplementary materials
Supplementary material associated with this article can be found, in
the online version, at doi:10.1016/j.jad.2019.08.039.
References
Aires, N., Selmer, R., Thelle, D., 2003. The validity of self-reported leisure time physical ac-
tivity, and its relationship to serum cholesterol, blood pressure and body mass index. A
population based study of 332,182 men and women aged 40–42 years. Eur. J. Epidemiol.
18 (6), 479–485.
Archer, T., Josefsson, T., Lindwall, M., 2014. Effects of physical exercise on depressive symp-
toms and biomarkers in depression. CNS. Neurol. Disord.Drug. Targets 13 (10),
1640–1653.
Bair, M.J., Wu, J., Damush, T.M., Sutherland, J.M., Kroenke, K., 2008. Association of depression
and anxiety alone and in combination with chronic musculoskeletal pain in primary care
patients. Psychosom. Med. 70 (8), 890–897. https://doi.org/10.1097/PSY.
0b013e318185c510.
Barengo, N.C., Antikainen, R., Borodulin, K., Harald, K., Jousilahti, P., 2017. Leisure‐time
physical activity reduces total and cardiovascular mortality and cardiovascular disease
incidence in older adults. J. Am. Geriatr. Soc. 65 (3), 504–510.
Bartley, C.A., Hay, M., Bloch, M.H., 2013. Meta-analysis: aerobic exercise for the treatment of
anxiety disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 45, 34–39.
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., 1961. An inventory for measuring
depression. Arch. Gen. Psychiatry 4, 561–571.
Chekroud, S.R., Gueorguieva, R., Zheutlin, A.B., Paulus, M., Krumholz, H.M., Krystal, J.H.,
Chekroud, A.M., 2018. Association between physical exercise and mental health in 1• 2
million individuals in the USA between 2011 and 2015: a cross-sectional study. Lancet
Psychiatry 5 (9), 739–746.
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., ..., Wang, P.S.,
2003. The epidemiology of major depressive disorder: results from the national co-
morbidity survey replication (NCS-R). JAMA 289 (23), 3095–3105.
Koponen, H., Kautiainen, H., Leppänen, E., Mäntyselkä, P., Vanhala, M., 2015. Association
between suicidal behaviour and impaired glucose metabolism in depressive disorders. BMC
Psychiatry 15 (1), 163.
Korniloff, K., Hakkinen, A., Kautiainen, H., Koponen, H., Peltonen, M., Mantyselka, P., ...,
Vanhala, M., 2010. Leisure-time physical activity and metabolic syndrome plus depressive
symptoms in the FIN-D2D survey. Prev. Med. 51 (6), 466–470. https://doi.org/10.1016/j.
ypmed.2010.09.007.
Penninx, B.W., Milaneschi, Y., Lamers, F., Vogelzangs, N., 2013. Understanding the somatic
consequences of depression: Biological mechanisms and the role of depression symptom
profile. BMC Medicine 11, 129.
Mammen, G., Faulkner, G, 2013. Physical activity and the prevention of depression: a sys-
tematic review of prospective studies. Am. J. Prev. Med. 45 (5), 649–657.
Mrazek, D.A., Hornberger, J.C., Altar, C.A., Degtiar, I., 2014. A review of the clinical, economic,
and societal burden of treatment-resistant depression: 1996–2013. Psychiatric Serv. 65 (8),
977–987. https://doi.org/10.1176/appi.ps.201300059.
Rosenbaum, S., Tiedemann, A., Sherrington, C., Curtis, J., Ward, P.B., 2014. Physical activity
interventions for people with mental illness. J. Clin. Psychiatry 75 (09), 964–974. https://
doi.org/10.4088/JCP.13r08765.
Schuch, F.B., Vancampfort, D., Firth, J., Rosenbaum, S., Ward, P.B., Silva, E.S., …, Stubbs, B.,
2018. Physical activity and incident depression: a meta-analysis of prospective cohort
studies. Am. J. Psychiatry 175 (7), 631–648. https://doi.org/10.1176/appi.ajp.2018.
17111194.
Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., ..., Dunbar,
G.C., 1998. The mini-international neuropsychiatric interview (MINI): the development
and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J.
Clin. Psychiatry 59, 22–23.
Sieverdes, J.C., Ray, B.M., Sui, X., Lee, D., Hand, G.A., Baruth, M., Blair, S.N., 2012. Association
between leisure time physical activity and depressive symptoms in men. Med. Sci. Sports
Exerc. 44 (2), 260–265. https://doi.org/10.1249/MSS.0b013e31822e00a6.
Sobocki, P., Jonsson, B., Angst, J., Rehnberg, C., 2006. Cost of depression in Europe. J. Mental
Health Policy Econ. 9 (2), 87–98. Retrieved from. http://ovidsp.ovid.com/ovidweb.cgi?
T=JS&PAGE=reference&D=emed7&NEWS=N&AN=2006325880.
Vancampfort, D., Firth, J., Schuch, F.B., Rosenbaum, S., Mugisha, J., Hallgren, M., ..., De Hert,
M., 2017. Sedentary behavior and physical activity levels in people with schizophrenia,
bipolar disorder and major depressive disorder: a global systematic review and meta‐a-
nalysis. World Psychiatry 16 (3), 308–315.
Walker, E.R., McGee, R.E., Druss, B.G., 2015. Mortality in mental disorders and global disease
burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72 (4),
334–341.
Whiteford, H.A., Degenhardt, L., Rehm, J., Baxter, A.J., Ferrari, A.J., Erskine, H.E., ..., Johns,
N., 2013. Global burden of disease attributable to mental and substance use disorders:
findings from the global burden of disease study 2010. The Lancet 382 (9904), 1575–1586.
World Health Organization. (2018). Obesity and overweight. (2018). Retrieved fromhttp://
www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
I. Raatikainen, et al. Journal of Affective Disorders 259 (2019) 150–153
153
